[Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Patients with osteogenesis imperfecta (OI) represent various degrees of bone fragility and accompany many clinical manifestations such as dentinogenesis imperfecta, blue sclera, growth disturbance, hearing impairment and so on. Although most OI is caused by genetic mutation of type I collagen gene ; COL1A1 and COL1A2, other genes that concerns post-translational modification of type I collagen molecules such as CRTAP, LEPRE1, PPIB, SERPINH1 and FKBP10 were found to be the causative candidates of OI. On the other hand, genetic causes of type V and type VI OI are not identified. For the classification of OI, Sillence's classification had been used and had been repeatedly revised at the times of identification of new causative genes of OI.

Original languageEnglish
Pages (from-to)1190-1195
Number of pages6
JournalClinical calcium
Volume20
Issue number8
Publication statusPublished - Aug 2010

Fingerprint

Osteogenesis Imperfecta
Collagen Type I
Dentinogenesis Imperfecta
Genes
Sclera
Post Translational Protein Processing
Hearing Loss
Bone and Bones
Mutation
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities]. / Hasegawa, Kousei.

In: Clinical calcium, Vol. 20, No. 8, 08.2010, p. 1190-1195.

Research output: Contribution to journalArticle

@article{93b2869662d74aa7958a7927337a9eb2,
title = "[Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].",
abstract = "Patients with osteogenesis imperfecta (OI) represent various degrees of bone fragility and accompany many clinical manifestations such as dentinogenesis imperfecta, blue sclera, growth disturbance, hearing impairment and so on. Although most OI is caused by genetic mutation of type I collagen gene ; COL1A1 and COL1A2, other genes that concerns post-translational modification of type I collagen molecules such as CRTAP, LEPRE1, PPIB, SERPINH1 and FKBP10 were found to be the causative candidates of OI. On the other hand, genetic causes of type V and type VI OI are not identified. For the classification of OI, Sillence's classification had been used and had been repeatedly revised at the times of identification of new causative genes of OI.",
author = "Kousei Hasegawa",
year = "2010",
month = "8",
language = "English",
volume = "20",
pages = "1190--1195",
journal = "Clinical calcium",
issn = "0917-5857",
publisher = "Iyaku (Medicine & Drug) Journal Co",
number = "8",

}

TY - JOUR

T1 - [Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].

AU - Hasegawa, Kousei

PY - 2010/8

Y1 - 2010/8

N2 - Patients with osteogenesis imperfecta (OI) represent various degrees of bone fragility and accompany many clinical manifestations such as dentinogenesis imperfecta, blue sclera, growth disturbance, hearing impairment and so on. Although most OI is caused by genetic mutation of type I collagen gene ; COL1A1 and COL1A2, other genes that concerns post-translational modification of type I collagen molecules such as CRTAP, LEPRE1, PPIB, SERPINH1 and FKBP10 were found to be the causative candidates of OI. On the other hand, genetic causes of type V and type VI OI are not identified. For the classification of OI, Sillence's classification had been used and had been repeatedly revised at the times of identification of new causative genes of OI.

AB - Patients with osteogenesis imperfecta (OI) represent various degrees of bone fragility and accompany many clinical manifestations such as dentinogenesis imperfecta, blue sclera, growth disturbance, hearing impairment and so on. Although most OI is caused by genetic mutation of type I collagen gene ; COL1A1 and COL1A2, other genes that concerns post-translational modification of type I collagen molecules such as CRTAP, LEPRE1, PPIB, SERPINH1 and FKBP10 were found to be the causative candidates of OI. On the other hand, genetic causes of type V and type VI OI are not identified. For the classification of OI, Sillence's classification had been used and had been repeatedly revised at the times of identification of new causative genes of OI.

UR - http://www.scopus.com/inward/record.url?scp=77958195237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958195237&partnerID=8YFLogxK

M3 - Article

C2 - 20675929

AN - SCOPUS:77958195237

VL - 20

SP - 1190

EP - 1195

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 8

ER -